Compare · head to head
Charles River Laboratories vs MaxCyte
Dead heat overall: both rank 17 on the 360° View.
Charles River Laboratories leads on Value (60 vs 49) and Quality (47 vs 35). MaxCyte leads on Growth (41 vs 36) and Safety (38 vs 19). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | X-Large | Small |
| ISIN | US1598641074 | US57777K1060 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 17 | 17 |
| Value | 60 | 49 |
| Quality | 47 | 35 |
| Growth | 36 | 41 |
| Safety | 19 | 38 |
| Sentiment | 50 | 49 |
| Quality details | ||
| Profitability | 44 | 28 |
| Cash Truth | 50 | 42 |
Charles River Laboratories vs InotivCharles River Laboratories vs Relay TherapeuticsCharles River Laboratories vs CertaraCharles River Laboratories vs MedpacesAdd a third stock →
Full analyses: Charles River Laboratories · MaxCyte
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100